Allotrap 2702 data

Investigators reported positive results of an initial Phase II study of Allotrap, showing it to be safe and well-tolerated.

As reported at the International Conference on New Trends in Clinical and Experimental Immunosuppression in Geneva, Switzerland, the French trial was a double-blind, randomized safety and pharmacokinetic study in 28 renal transplant recipients. ...